GSE129698 SYK inhibition 6 v 4 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE129698_SYK inhibition_6_v_4_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE129698_SYK inhibition_6_v_4_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE129698_SYK inhibition_6_v_4_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE129698_SYK inhibition_6_v_4_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

MT-CO2 pseudogene 12

Gene

napsin B aspartic peptidase (pseudogene)

Gene

WAS protein family homolog 8, pseudogene

Gene

H3 clustered histone 4

Gene

FRMD6 antisense RNA 1

Gene

cytochrome P450 family 21 subfamily A member 1, pseudogene

Gene

VAV3 antisense RNA 1

Gene

PMS1 homolog 2, mismatch repair system component pseudogene 14

Gene

ribosomal protein L7 pseudogene 45

Gene

yippee like 3

  • Gene

    MT-CO2 pseudogene 12


  • Gene

    napsin B aspartic peptidase (pseudogene)


  • Gene

    WAS protein family homolog 8, pseudogene


  • Gene

    H3 clustered histone 4


  • Gene

    FRMD6 antisense RNA 1


  • Gene

    cytochrome P450 family 21 subfamily A member 1, pseudogene


  • Gene

    VAV3 antisense RNA 1


  • Gene

    PMS1 homolog 2, mismatch repair system component pseudogene 14


  • Gene

    ribosomal protein L7 pseudogene 45


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.